It looks as though they are trying to work this out, and not struggling with the go / no-go issue on drug approval. I would be optimistic, and am in fact, being long.
<<"Due to the expected timing of ongoing inspections and reporting of the results, which will affect completion of other parts of the overall review process, GTC is now anticipating the EMEA's opinion in February 2006.">>